Your browser doesn't support javascript.
loading
Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma.
Samadaei, Mahzeiar; Senfter, Daniel; Madlener, Sibylle; Uranowska, Karolina; Hafner, Christine; Trauner, Michael; Rohr-Udilova, Nataliya; Pinter, Matthias.
Afiliação
  • Samadaei M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Senfter D; Liver Cancer (HCC) Study Group Vienna, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Madlener S; Department of Pediatrics and Adolescent Medicine, Molecular Neuro-Oncology, Medical University of Vienna, Vienna, Austria.
  • Uranowska K; Department of Pediatrics and Adolescent Medicine, Molecular Neuro-Oncology, Medical University of Vienna, Vienna, Austria.
  • Hafner C; Department of Dermatology, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria.
  • Trauner M; Center for Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
  • Rohr-Udilova N; Department of Dermatology, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria.
  • Pinter M; Karl Landsteiner Institute of Dermatological Research, Karl Landsteiner Gesellschaft, St. Poelten, Austria.
J Cell Biochem ; 123(10): 1663-1673, 2022 10.
Article em En | MEDLINE | ID: mdl-36271841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article